Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0001193125-25-211363

10% owner sold 135,304 shares at an average $42.23 ($5,714,356)

From the SEC's structured data for this filing

Trades in this filing

Versant Venture Capital VI, L.P. · 10% owner

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-18 Sale : show line 1 in the form −49,479 $41.59 $2,057,871 1,224,718 D
2025-09-18 Sale : show line 2 in the form −24,370 $41.59 $1,013,568 876,437 I
2025-09-18 Sale : show line 3 in the form −40,907 $43.00 $1,759,156 1,183,811 D
2025-09-18 Sale : show line 4 in the form −20,148 $43.00 $866,441 856,289 I
2025-09-18 Sale : show line 5 in the form −268 $43.30 $11,604 1,183,543 D
2025-09-18 Sale : show line 6 in the form −132 $43.30 $5,716 856,157 I
Open-market sales · 135,304 sh · avg $42.23 · $5,714,356
Loading xslF345X05/ownership.xml…